BIO 2018

The BIO International Convention Begins Day Three with Keynote Speech from Actor, Director and Advocate Rob Reiner

Wednesday programming will emphasize the patient and the role of the biotech industry in delivering care

Boston, MA – (June 6, 2018) – The 2018 BIO International Convention, the world’s premier life sciences event, entered its third day of compelling programming under the theme “Make History.” Hosted by the Biotechnology Innovation Organization (BIO), the Convention will run through Thursday, June 7, at the Boston Convention & Exhibition Center.

During today’s keynote, Jim Greenwood, President and CEO of BIO will interview actor, director and advocate Rob Reiner, who will share his poignant story of helping his son overcome his battle with drug addiction. During this week’s Convention, industry leaders and researchers are gathered to discuss strategies to stem the opioid crisis and progress in discovering next-generation non-addictive pain therapies.
Following the keynote, multiple sessions will focus on digital health, patient access and delivering value to patients. A special performance by Diana Ross at Ballroom Level will cap off day three of the Convention.

The exhibit hall will feature the BIO Patient Advocacy Pavilion with 62 separate patientadvocacy organizations there to share perspectives and learn more about drug discovery and clinical development initiatives, enrollment optimization, clinical protocol and trial design.

Wednesday, June 6 Highlights Include:

Join us for a fireside chat with former Massachusetts Governor Deval Patrick.
11:00 a.m. – 12:00 p.m. l Room 205ABC, Level 2

Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. Stop by Start-Up Stadium between education sessions or meetings to watch these impressive companies pitch their products to a panel of investor judges.
11:00 a.m. – 1:00 p.m. | Level 1 North Lobby
02:00 p.m. – 4:00 p.m. | Level 1 North Lobby
A fireside chat with John Maraganore, PhD, CEO at Alnylam Pharmaceuticals. Dr. Maraganore is leading Alnylam as they prepare to launch the first RNAi therapy. Prior to joining Alnylam, he held senior leadership roles at Millennium Pharmaceuticals, Biogen and ZymoGenetics.
2:00 p.m.– 3:00 p.m. l Room 254A, Level 2 

A fireside chat with Mikael Dolsten, MD, PhD, President of Worldwide Research and Development at Pfizer. Dr. Dolsten is focused on advancing Pfizer’s scientific leadership in small molecule medicines, biotherapeutics and vaccines. 
3:30 p.m. – 4:30 p.m. l Room 254A, Level 2 

BIO One-on-One Partnering isn't the only aspect of BIO 2018 that is making history!
This year, we have more speakers, more sessions, and more programming options than ever before at BIO 2018 in Boston including 180+ sessions, 850+ speakers, 8 Super Sessions, and 9 Fireside Chats in 19 Education Tracks. Below you can find a list of some can't miss sessions in our most popular tracks.
Take a look, and add the sessions you want to attend to your personalized myBIO agenda!
Register Now

View Schedule
Note: Most Education Sessions are open to Education Access and above registrants. 
Featured Tracks:
View myBIO
Special Programs
Featured Special Programs
Register Now

View Schedule

Education + Programming Open to All Attendees
Not all of the BIO 2018 Education Program is limited to just Education Access and above registrants. Here is a list of interactive programming around the Boston Convention & Exhibition Center that is open to all attendees:

Around the World in 4 Days:
International Programming at BIO 2018
The biotechnology industry is becoming increasingly global. The 2018 BIO International Convention brings the global industry and policy leaders to Boston, Massachusetts. Join us at the Emerging Opportunities in Global Markets track to interact with high level government officials as well as industry experts and leaders from Europe to China on the various opportunities and challenges facing the industry.
Featured Events:
Register Now
Log in to myBIO and add these sessions to your personalized event schedule.
Featured Sessions:
Global Leadership Forum
Tuesday, June 5 | 1:00pm – 5:30pm
With each passing year, biotechnology becomes more of a globalized technology, with research and commercialization efforts reaching new corners of the world. The Global Leadership Forum features three panels featuring influential high-level officials from across the globe. The Forum panels include:
  • The Honorable Mmamoloko Kubayi-Ngubane, Minister of Science & Technology, Republic of South Africa
  • The Honorable Gérard Araud, Ambassador to the United States, French Republic
  • The Honorable Gintaras Vilda, Vice Minister of Economy, Republic of Lithuania
Australia: Island of Research and Innovation
A Fireside Chat with the Honourable Greg Hunt MP, Minister for Health, Commonwealth of Australia
2:30 PM – 2:55 PM
  • Nares Damrongchai, CEO, Thailand Center of Excellence for Life Science
  • Douglas Doerfler, President & Chief Executive Officer, MaxCyte
  • Barbara Weisel, Former Chief US Negotiator, Trans-Pacific Partnership (TPP)
  • Karen Antebi, Economic Counselor of Mexico to the U.S

China Summit @ BIO International
Monday, June 4 | 12:00pm – 5:00pm
Join us to bridge innovation, enterprise and culture from Boston to China. The Summit will examine recent watersheds in China’s regulatory, policy, and industrial reforms positioned to create a globally competitive biopharmaceutical industry in China, as well as successful models for cross-border alliances and partnerships.
Panel discussions will include viewpoints from a broad range of China experts and industry leaders, covering the following areas:
  • Blueprint for China’s Healthcare Reform
  • Key Issues Today: Regulatory, IP, and Innovation
  • New Economy Life Sciences Transforming Global Markets
  • Trends in Financing, Capital Markets and Cross Border BD
Seating Begins at 11:45am; Box Lunches Available
View Schedule

Register Now
Global Innovation Hubs
This track features substantive and high-level discussions on specific initiatives at the national or regional level to support biotechnology innovation. View all sessions in this track.
Tour the Life Sciences Region Around Boston
Join us as we explore one of the world’s leading biotechnology hubs in a full day of tours throughout the Massachusetts biotech community. Attend one of the site, lab, and incubator tours arranged by BIO and the Massachusetts Life Sciences Community.
Sign-ups are first come, first served and spaces are extremely limited. Most tours are held on Monday, June 4, and the $35 fee covers transportation to and from the Boston Convention & Exhibition Center. Separate registration is required.

BIO International Convention
Wednesday Keynote Announced: Rob Reiner
Rob Reiner first came to fame as a two-time Emmy Award winning actor on the landmark television series “All In the Family.” He went on to become an acclaimed director of some of the most popular and influential motion pictures. His work ranges from the satire This Is Spinal Tap to intense dramas like Stand By Me, Misery, A Few Good Men, and Ghosts of Mississippito romantic comedies like When Harry Met Sally, The American President,and The Princess Bride. His more recent films include The Bucket List, Flipped, Being Charlie and LBJ starring Woody Harrelson. This summer sees the release of Shock and Awe, about four journalists who try to expose the lies told in the run up to the war in Iraq. It stars Woody Harrelson, Tommy Lee Jones, James Marsden and Reiner himself.
Reiner is also a vigorous political activist and was instrumental in establishing the California Children & Families Commission, which he chaired for seven years. 
Learn more about our impressive keynote speaker, and watch his keynote live at BIO 2018 on Wednesday, June 6 at 9:00am.
Learn More

Register Now
Keynotes are open to Convention Access and Convention Access and Partnering registrants. 
Best Value Package:
Convention Access + Partnering
Access everything the BIO International Convention has to offer including 45,000+ meetings between 6,000+ companies in BIO One-on-One Partnering™, the expansive BIO Exhibition, impressive networking receptions including Diana Ross in concert, keynotes, 170+ breakout sessions, 8 Super Sessions and 9 Fireside Chats.

This is the premier registration package, and gives you access to the BIO Business Forum.
$2,400 for BIO Members
$3,000 for Non-Members
Register Now
Featured Track
Opioids: Changing the Paradigm on Treating Pain and Addiction
The use and misuse of opioids is a public health crisis. Over 2.5 million in the United States have an opioid use disorder and over 80 people die each day of an overdose. Furthermore, four out of five individuals begin using heroin by first misusing opioid prescription drugs and there are over 200 million opioid prescriptions written each year. In additional to the cost in human lives, the financial cost of substance misuse is staggering. The cost to federal, state, and local governments is $467.7 billion per year; the cost to public and private medical insurers is $72.5 billion; 5.2 million people use opioids annually generating $8 billion in annual opioid sales. Inappropriate prescribing is the fundamental upstream driver of the opioid epidemic. This one day program will discuss opportunities and solutions that the biotechnology industry can provide to help curtail this epidemic.
Heralding a New Era of Precision Medicine
Biotechnology Innovation Organization

Celebrating 25 Years of BIO Innovation
Don't miss the most influential global leaders in biotechnology and pharma discussing innovation, vaccines, gene therapy, precision medicine, and the 2018 global forecast in this year's lineup of Super Sessions at BIO 2018!
Explore the sessions below, and add the ones you want to see to your personalized myBIO agenda. Check back often as additional speakers are confirmed!
Super Sessions are open to Education Access, Convention Access, and Convention Access + Partnering registrants.
Register Now

View Full Program

What’s Next: The Landscape of Innovation in 2018 and Beyond
Sponsored by: ClearView Healthcare Partners

What’s next for R&D in the global pharmaceutical industry, highlighting noteworthy differences in disease areas of focus, and therapeutic targets for companies of all sizes. 
Sam Ulin
Sam Ulin, Principal, ClearView Healthcare Partners
Newton, Massachusetts
Also Featuring:
  • Chris Von Seggern, Partner, ClearView Healthcare Partners

The Business of Biotech and Sports
Sponsored by: Sanofi Genzyme

Explore the similarities between running a successful biotech company and a football franchise: team building, collaborations, innovation, leadership, culture, and more.
Jonathan Kraft
Jonathan Kraft, President, The Kraft Group and the New England Patriots
Foxborough, Massachusetts
Also Featuring:
  • Bill Sibold, Executive Vice President and Head, Sanofi Genzyme

The Global Vaccines Business: A View from the Top
Sponsored by: Merck & Co., Inc.

The opportunities and challenges facing vaccine developers and manufacturers and the importance of continued innovation in vaccines. 
Michael Nally
Michael Nally, President, Merck Vaccines
Philadelphia, Pennsylvania
Also Featuring:
  • Stanley Erck, President and Chief Executive Officer, NOVAVAX
  • Jacqueline Keith [Moderator], President, J Keith Consulting Corp
  • David Loew, Head, Global Commercial Operations, Sanofi Pasteur
  • Gordon Naylor, President, Sequirus
  • Rajeev Venkayya, President, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited

Deal makers explore the impact that market forces have on pharmaceutical and biotech companies.
Neel Patel
Neel Patel [Moderator], Managing Director, Portfolio & Commercial Strategy, Syneos Health Consulting
San Francisco, California
Also Featuring:
  • Marianne De Backer, PhD, MBA, Vice President, Venture Investments, Johnson & Johnson Innovation
  • Ji Li, Executive Vice President, Global Head of Business Development, BeiGene, Ltd.
  • David Thomas, CFA, Managing Director, Industry Research and Policy Analysis, Biotechnology Innovation Organization (BIO)
  • Dr. Thomas Zioncheck, Global Head, Genentech Business Development for Neuroscience, Ophthalmology, and Research Tools & Technologies, Genentech, A Member of the Roche Group

Delivering on the Promise of Gene Therapy
Sponsored by: FUIJIFILM Diosynth Biotechnologies

Improving human health, potential treatments and cures for disease, and new approaches to drug delivery. 
Steve Bagshaw
Steve Bagshaw [Moderator], Chief Executive Officer, FUJIFILM Diosynth Biotechnologies
Billingham, United Kingdom
Also Featuring:
  • Sandy Macrae, President and Chief Executive Officer, Sangamo Therapeutics
  • John Pieracci, Director, Gene Therapy Process Development, Biogen
  • Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer

Heralding in a New Era of Precision Medicine
Sponsored by: Bristol-Myers Squibb

The intersection of biology, computer science, statistics, and engineering and the future of precision medicine.
Dr. Thomas J. Lynch, Jr.
Dr. Thomas J. Lynch, Jr. [Moderator], Executive Vice President, Chief Scientific Officer, Bristol-Myers Squibb
Princeton Pike, New Jersey
Also Featuring:
  • Melanie Nallicheri, Chief Business Officer and Head of Biopharma, Foundation Medicine
  • Scott D. Solomon, The Edward D. Frohlich Distinguished Chair Professor of Medicine, Harvard Medical School

How are advances in hardware, software, and mobile technologies reconstructing the delivery of healthcare? 
Rachel Sha
Rachel Sha [Moderator], Vice President, Digital Business Development & Licensing, Sanofi
Boston, Massachusetts
Also Featuring:
  • Marta Bralic, Vice President, Business Development, FlatIron Health
  • Dr. Luba Greenwood, Strategic Business Development, Corporate Ventures at Verily, an Alphabet Company
  • Dr. Iya Khalil, Chief Commercial Officer, EVP and Co-founder, GNS Healthcare

The latest commercial, scientific and ethical issues facing innovation stakeholders today, and what to expect in the year ahead.
Kate Bingham
Kate Bingham, Managing Partner, SV Health Investors
London, United Kingdom
Also Featuring:
  • Jorge Aguado, Vice Minister of Science, Argentina
  • Kevin Ali, President, MSD International, Merck & Co, Inc.
  • Lisa Melton [Moderator], Senior News Editor, Nature Biotechnology
  • Kenneth Kaitin, Professor of Medicine and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
Register Now

View Full Program
Bristol-Myers Squibb

ClearView Healthcare Partners
FUIJIFILM Diosynth Biotechnologies

Merck & Co., Inc.

Sanofi Genzyme
Syneos Health

2018 BIO International Convention
BIO Exhibition Overview
Thousands of Innovative Companies, Events, and Attendees at BIO 2018
The expansive BIO Exhibition is packed with the latest trends, technology, companies, and breakthrough ideas in biotechnology and pharma. We have over 1,800 exhibiting companies including 50+ Domestic and International Pavilions and 4 Product Focus Zones like the brand new Emerging Innovators Zone, as well as special areas in the BIO Exhibition such as Company PresentationsHeadshot LoungeMeetups, and more!
Join us for another record breaking year! Explore the BIO Exhibition, preview the schedule, and take a look at who you can meet in Boston next month.
BIO Exhibition Hours:
Tuesday, June 5; 10:00 am - 6:30 pm*
Wednesday, June 6; 10:00 am - 5:30 pm
Thursday, June 7; 10:00 am - 4:30 pm
*Note: BIO Exhibitor Hospitality Receptions are from 5:00 - 6:30 pm on Tuesday. Stop by and see these participating companies.
Register Now

Learn More

Exhibitor Spotlight:
Meet These Companies in the BIO Exhibition
3Sixty Pharma Solutions
3Sixty Pharma Solutions is the industry’s only clinical research-to-commercialization solution. We provide functional and consulting services to Pharmaceutical, Biotechnology, and Medical Device companies. Our highly-experienced Experts and Project Managers are nimble innovators and problem-solvers: we repair projects, fix processes, manage business-critical ventures, and tailor transformative solutions that foster sustainable change. Let’s start a conversation about how we can help reinforce your efforts to advance cutting-edge patient care.
Booth #1952
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience.
Booth #2043
Alkermes plc is a fully integrated, global biopharmaceutical company focused on developing innovative medicines for the treatment of chronic central nervous system diseases and cancer. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, multiple sclerosis and cancer.
Alnylam is leading the translation of RNA interference (RNAi) into an innovative new class of medicines with the potential to transform the lives of people with rare genetic, cardio-metabolic, and hepatic infectious diseases. Alnylam’s pipeline of investigational medicines includes four late-stage product candidates, with one under regulatory review in the US and Europe.
American Laboratory Trading, Inc.
ALT is BIO Business Solution’s® exclusive provider of premium refurbished lab equipment and surplus asset management. BIO members receive a free 1-year warranty and pricing discounts on all purchases. With more than 12,000 items in stock, ranging from benchtop accessories to robust triple quad mass spectrometers, we carefully test and service each instrument to ensure it meets manufacturer specifications
Bio-Rad Laboratories
Bio-Rad has partnered with Drug Discovery, Development, and Manufacturing researchers for over 60 years, delivering innovative solutions that support scientists with customizable workflows. Learn how we provide research solutions that truly enable you to get to market faster with the right molecule while reducing downtime, errors, and waste.
Booth #2306
Cipher is a full-service competitive strategy and technology firm. We provide world-class consulting services and technology solutions that help Life Sciences companies gain and maintain a competitive edge. Our latest technology innovation, Knowledge360® is an all-in-one, cloud-based competitive intelligence solution that automates the collection and organization of information, allowing users to collaborate in real-time to develop strategic insights.
Cryosite Australia
Cryosite Australia
Cryosite is Australia’s most trusted provider of depot services for temperature-sensitive life sciences materials, serving biotech, research and clinical trial sponsors around the world. The leading provider of specialist ultra-low temperature and cryogenic storage, Cryosite has the capability to meet your biorepository requirements. With a strong client profile, Cryosite is the proven and experienced leader in Ph.II-IV trial depot distribution
FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies
Booth #863A and 863B
As a CDMO our focus is to combine technical leadership in cell culture, microbial fermentation and viral vectors with world class GMP manufacturing facilities to advance tomorrow’s medicines. We have delivered over 310 molecules including monoclonal antibodies, recombinant proteins, viral vaccines and gene therapies at all stages of the clinical development. We have completed 26 Process Validation programs and are licensed to manufacture 6 commercial products. We have facilities in College Station, Texas, RTP, North Carolina and Billingham, United Kingdom.
Labscape provides Academic Institutions, Pharmaceutical and Biotech Companies with the following material and services:
  • Industry leading fume hoods and modular lab furniture
  • FREE laboratory design proposals
  • Project Installation/Coordination 
Come visit us at Booth 1806 to learn more!
Merrill Corporation
Merrill DatasiteOne - The only SaaS application for due diligence. DatasiteOne helps companies worldwide close more deals, faster, with the strongest combinations of deal making and reporting support. For the first time, organizations can carry out, from beginning to end, essential business communications, execute critical transactions, and meet global regulatory requirements — all via a secure, controlled and easy-to-use platform.
Visit the BIO Pavilion

Featured Zones in the BIO Exhibition
BioProcess Theater
Interactive Amphitheater in the BioProcess Zone
Since 2008, the BPI Theater, located at the heart of the BioProcess Zone, provides biopharmaceutical professionals with a dedicated destination to meet, network, listen and learn about the latest scientific, technology, business, and financial trends impacting biopharmaceutical research, development, and manufacturing.
Emerging Innovators Zone
Newest Zone in the BIO Exhibition
This brand new area in the BIO Exhibition showcases independent small and medium-sized enterprises that are post-$10M investment. The “open-air market” atmosphere allows attendees to freely engage with companies who are further along in their company life cycle to exchange ideas and information to achieve continual stages of growth.
Don't Miss the Headshot Lounge
Yoga Class at BIO 2018
View Sessions, Speakers and more in myBIO
Biotechnology Innovation Organization

25 Years of Innovation

No comments:

Post a Comment